Parnassus Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,626
Closed -$245K 134
2023
Q3
$245K Buy
2,626
+92
+4% +$10.4K ﹤0.01% 135
2023
Q2
$326K Hold
2,534
﹤0.01% 128
2023
Q1
$294K Buy
2,534
+645
+34% +$72.2K ﹤0.01% 130
2022
Q4
$214K Buy
+1,889
New +$207K ﹤0.01% 132

Other funds holding DXCM

Parnassus Investments's DXCM Position: Q4 2023 in Review

Parnassus Investments sold out of DexCom (DXCM) in Q4 2023, closing a stake of 2,626 shares — an estimated $245K sold.

Parnassus Investments first reported a position in DXCM in Q4 2022 and held it in 4 quarters. The position peaked at $326K in Q2 2023. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Parnassus Investments reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Parnassus Investments sold 2,626 DexCom shares in Q4 2023, an estimated $245K.
  • Parnassus Investments first reported a position in DexCom in Q4 2022 and held it in 4 quarters.
  • Parnassus Investments's DexCom position peaked at $326K in Q2 2023.
  • 975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Parnassus Investments's 13F filing for Q4 2023, filed 12 Feb 2024.